-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

BRIEF-Amolyt Pharma Announces $138 Million Series C Financing Led By Sofinnova Partners And Co-Led By Intermediate Capital Group

Reuters · 01/06/2023 16:04
BRIEF-Amolyt Pharma Announces $138 Million Series C Financing Led By Sofinnova Partners And Co-Led By Intermediate Capital Group

-

  • AMOLYT PHARMA ANNOUNCES $138 MILLION SERIES C FINANCING LED BY SOFINNOVA PARTNERS AND CO-LED BY INTERMEDIATE CAPITAL GROUP

  • AMOLYT PHARMA- PLANS TO USE PROCEEDS TO ADVANCE ITS PIPELINE OF THERAPEUTICS FOR RARE ENDOCRINE AND RELATED DISORDERS

Source text for Eikon: ID:


((Reuters.Briefs@thomsonreuters.com;;))